Volume 1019, Issue 1 p. 360-364

Senescence Marker Protein-30 as a Novel Antiaging Molecule

DONGYUN FENG

DONGYUN FENG

Department of Molecular Pathology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan

Department of Regulation Biology, Faculty of Science, Saitama University, Saitama, Japan

Search for more papers by this author
YOSHITAKA KONDO

YOSHITAKA KONDO

Department of Molecular Pathology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan

School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan

Search for more papers by this author
AKIHITO ISHIGAMI

AKIHITO ISHIGAMI

Department of Molecular Pathology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan

Search for more papers by this author
MASASHI KURAMOTO

MASASHI KURAMOTO

Department of Molecular Pathology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan

Search for more papers by this author
TAKEO MACHIDA

TAKEO MACHIDA

Department of Regulation Biology, Faculty of Science, Saitama University, Saitama, Japan

Search for more papers by this author
NAOKI MARUYAMA

Corresponding Author

NAOKI MARUYAMA

Department of Molecular Pathology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan

Address for correspondence: Naoki Maruyama, M.D., Department of Molecular Pathology, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakaecho, Itabashi-ku, Tokyo 173-0015, Japan. Voice: +813-3964-3241; fax: +813-3579-4776. [email protected]Search for more papers by this author
First published: 12 January 2006
Citations: 19

Abstract

Abstract: Senescence marker protein-30 (SMP30), composed of 299 amino acids, has an approximate molecular mass of 32-34 kDa and has a pI 4.9 in charge. The amino acid alignment from various animal species revealed a highly conserved structure. SMP30 has an enzyme activity hydrolyzing sarin, soman, and tabun, known as lethal toxic nerve chemicals. We analyzed the organophosphatase activity of SMP30 using DFP as a substrate. This DFPase activity is revealed in a dose-dependent manner in the presence of magnesium ions. We investigated the intracellular localization of SMP30. It is localized in both the cytoplasm and nucleus. To confirm the presence of SMP30 in the nucleus, we prepared nuclear and cytoplasmic extracts from isolated cultured hepatocytes. Western blotting showed that SMP30 was detected in both extracts. Because the expression is reduced by carbon tetrachloride, one can speculate that the expression is modulated by oxidative stress increased with aging.